SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 49 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,667,000 | -29.3% | 274,074 | +7.0% | 0.65% | -39.1% |
| Q3 2017 | $3,771,000 | +28.7% | 256,215 | +40.7% | 1.06% | -1.8% |
| Q2 2017 | $2,931,000 | +1.0% | 182,141 | 0.0% | 1.08% | -36.7% |
| Q1 2017 | $2,902,000 | +31.0% | 182,141 | 0.0% | 1.71% | -6.4% |
| Q4 2016 | $2,215,000 | +219.2% | 182,141 | +264.3% | 1.83% | +225.4% |
| Q3 2016 | $694,000 | -23.6% | 50,000 | 0.0% | 0.56% | -37.8% |
| Q2 2016 | $908,000 | – | 50,000 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |